Sox9 Modulates Proliferation and Expression of Osteogenic Markers of Adipose-Derived Stem Cells (ASC) by Stöckl, Sabine et al.
Cell Physiol Biochem 2013;31:703-717
DOI: 10.1159/000350089
Published online: May 16, 2013
© 2013 S. Karger AG, Basel
www.karger.com/cpb 703





 Copyright © 2013 S. Karger AG, Basel
Accepted: April 22, 2013 
This is an Open Access article licensed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online 
version of the article only. Distribution for non-commercial purposes only.
Dept. of Orthopaedics, University of Regensburg




Sox9 Modulates Proliferation and 
Expression of Osteogenic Markers of 
Adipose-Derived Stem Cells (ASC)
Sabine Stöckla,b   Claudia Göttla,b    Joachim Grifkab    Susanne Grässela,b
aCentre for Medical Biotechnology, BioPark I, University of Regensburg, Regensburg, Germany; 




Background: Mesenchymal stem cells (MSC) are promising tools for tissue-engineering 
and musculoskeletal regeneration. They reside within various tissues, like adipose tissue, 
periosteum, synovia, muscle, dermis, blood and bone marrow, latter being the most common 
tissue used for MSC isolation. A promising alternative source for MSC is adipose tissue due to 
better availability and higher yield of MSC in comparison to bone marrow. A drawback is the 
yet fragmentary knowledge of adipose-derived stem cell (ASC) physiology in order to make 
them a safe tool for in vivo application. Methods/Results: +HUHZHLGHQWLÀHG6R[DVDKLJKO\
expressed and crucial transcription factor in undifferentiated rat ASC (rASC). In comparison 
to rat bone marrow-derived stem cells (rBMSC), mRNA and protein levels of Sox9 were 
VLJQLÀFDQWO\KLJKHULQU$6&7RVWXG\WKHUROHRI6R[LQGHWDLOZHVLOHQFHG6R[ZLWKVK51$LQ
rASC and examined proliferation, apoptosis and the expression of osteogenic differentiation 
PDUNHUV2XUUHVXOWVFOHDUO\SRLQWWRDGLIIHUHQFHLQWKHH[SUHVVLRQSURÀOHRIRVWHRJHQLFPDUNHU
genes between undifferentiated rASC and rBMSC in early passages. Sox9 silencing induced the 
expression of osteocalcin, VegfD and Mmp13, and decreased rASC proliferation accompanied 
with an induction of p21 and cyclin D1 expression and delayed S-phase entry. Conclusions: 
We suggest a pro-proliferative role for Sox9 in undifferentiated rASC which may explain the 
higher proliferation rate of rASC compared to rBMSC. Moreover, we propose an osteogenic 
differentiation delaying role of Sox9 in rASC which suggests that Sox9 expression is needed to 
maintain rASC in an undifferentiated, proliferative state.
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Mesenchymal stem cells (MSC) are able to self-renew and to differentiate into several 
lineages, i.e. chondrocytes, osteocytes or adipocytes and thus MSC are a highly attractive 
alternative for usage in tissue-engineering and regenerative medicine.
In the past, adult MSC were commonly isolated from bone marrow. Bone marrow- 
derived stem cells (BMSC) form only 0.001– 0.01% of total nucleated cells in the aspirate [1] 
and, require therefore a considerable amount of primary cell material or a time consuming 
expansion period. Moreover, comorbidity constitutes a problem, as it is always required to 
induce a bone defect to aspirate the bone marrow. 
Today it is known that MSC can be found in nearly all adult tissues, e.g. adipose tissue, 
dermis, periosteum, peripheral and menstrual blood and in solid organs like liver, spleen 
and lung [2-4]. Therefore, adipose-derived MSC (ASC) qualify as an excellent alternative to 
BMSC. Advantages are the abundance of adipose tissue in the body of mammals and its easy 
accessibility as it is often prone to disposal as medical waste [5]. In addition, the method 
of obtaining a lipo-aspirate is less invasive and expensive which is in part attributable to 
the fact that adipose tissue displays a 2500-fold higher frequency of stem cells compared to 
bone marrow [6]. Molecular characteristics in terms of their immunosuppressive properties 
show that ASC behave similar to BMSC [7]. Recent studies related to bone tissue-engineering 
using ASC in combination with several clinically available biomaterials and scaffolds show 
promising results.  
In a self-designed bioreactor, Fröhlich et al. cultured a scaffold construct seeded with 
human ASC and reported a profound increase in osteogenic differentiated cells and bone 
matrix formation [8]. Animal model studies support the idea that ASC are of interest for 
the fabrication of tissue-engineered bone in vitro. Notable, autologous ASC improved bone 
regeneration in a critical-sized skull defect of adult New Zealand white rabbits, when they 
 Ǧ   ϐǦ
cylindrical PLA (poly-L-lactic acid) scaffold [9].
It is known that culture time and passage number of MSC in general, and ASC in 
particular crucially affect their biological activities and their immunophenotype.
Different studies have compared and characterized the immunophenotype of freshly 
isolated ASC with serial passaged ASC, and found that during culture time the expression 
ϐ
progressively while other markers as endothelial associated molecules remained unaffected 
[10, 11]. One reason is certainly the well known heterogeneity of fresh ASC preparations 
which most likely affects biological properties beside the expression of surface markers. 
Further, it is described that long-term in vitro expansion of human ASC affects osteogenic 
differentiation capacity negatively and increases cell senescence. After long-term in vitro 
expansion culture, ASC were able to differentiate into immature osteoblast-like cells only 
[12, 13]. Hence, a short-term expansion period of undifferentiated ASC in combination 
ϐ
therapeutically use. In this light, the physiology of ASC needs still in depth characterization 
to assure that there is no loss or alteration of the cellular or molecular phenotype during ex 
vivo culture and differentiation and subsequent in vivo application.
Sox9 is mainly described as the master transcription factor for chondrogenic 
differentiation and is expressed in all osteo-chondroprogenitor cells and chondrocytes. 
It is required for mesenchymal condensation and inhibition of precocious hypertrophic 
conversion of proliferating chondrocytes during embryonic chondrogenesis [14, 15]. Several 
recent studies have demonstrated that Sox9 is also well expressed in adult tissues [16]. Sox9 
is not only crucial for chondrogenic differentiation of BMSC [17, 18] but also of MSC from 
other sources. Yang et al. showed that Sox9 facilitates the differentiation of adipose tissue-
derived stem cells into a chondrocyte-like phenotype in vitro [19].
In addition to its critical involvement in chondrogenic differentiation during 
musculoskeletal development, Akiyama et al. suggest that osteo-chondroprogenitor 
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cells, derived from mesenchymal stem cells, adopt an osteogenic phenotype when Sox9 
expression is lower than Runx2 expression which is supported by a delayed endochondral 
bone formation in Sox9 knock-in heterozygous mutant mice [16, 20]. In addition, when Sox9 
    ʹǦ ǡ   ϐ
process appears abnormal, indicating that Sox9 is able to inhibit regulators of osteoblast 
development [21]. The role of Sox9 for chondrogenesis has already been thoroughly studied 
in BMSC [17, 22, 23] as well as in ASC [24] but only little is known about the role of Sox9 in 
undifferentiated MSC and BMSC or ASC osteogenesis [25]. Lee et al. determined in their study 
the potential of SOX-trio co-transduced ASC (Sox9, Sox5 and Sox6) to repair osteochondral 
defects and to delay the progression of osteoarthritic lesions in a rat model and showed 
     ϐ   ͻ  
in a surgically-induced osteoarthritis model [24]. Besides being an important transcription 
factor for proper differentiation and developmental processes, Sox9 is moreover known 
to affect the proliferation and cell cycle distribution in several cells and tissues. In lung 
adenocarcinoma, a Sox9 knockdown resulted in an upregulation of p21 and thus in a marked 
decrease of adhesive and anchorage-independent growth and is suggested to contribute to 
gain of tumor growth potential, possibly acting through affecting the expression of cell cycle 
regulators p21 and CDK4 [26]. P21 is well known as an negative regulator of the cell cycle 
[27], but recently other roles for p21 beside being a cell cycle inhibitor are reported. In this 
context, apoptosis, hypertrophy and cell morphology in different cell types could be affected 
via p21, depending on the subcellular localization of the protein [28]. 
In this study, we detected a strong induction of Sox9 in ASC compared to BMSC, and 
      ϐ    Ǥ
We therefore focused on Sox9 and observed an impact of this transcription factor on 
proliferation of ASC, accompanied by an increased p21 and cyclin D1 protein expression. 
Silencing Sox9 had a clearly stimulating effect on osteocalcin and Mmp13 gene expression in 
undifferentiated and osteogenic differentiated ASC. Matrix mineralization as an indicator for 
successful osteogenic differentiation is also reduced after Sox9 silencing. 
Materials and Methods
Isolation and culture of rASC and rBMSC 
ȏʹͻǡ͵ͲȐȏ͵ͳȐϐ










passage 1 and passage 2 cells (1x106) were suspended in PBS containing following conjugated antibodies 
ǣ	ǦͻͲȋǡ	ǡǡǡ#554897), 
Ǧͳͳȋǡ	ǡǡǡ # 562105)ǡǦ
ͷǦ   Ͷͷ ȋǡ 	 ǡ ǡǡ͓ͷͷͻͳ͵ͷȌǤ
ϐ	ȋǡ	ǡǡǡ #ͷͷͲ͸ͳ͸Ȍǡȋ
ǡ	ǡǡǡ#562141)Ǧͷȋǡ	ǡ




Cell Physiol Biochem 2013;31:703-717
DOI: 10.1159/000350089
Published online: May 16, 2013
© 2013 S. Karger AG, Basel
www.karger.com/cpb 706
Stöckl/Göttl/Grifka/Grässel: Sox9 in Adipose-Derived Stem Cells
Cellular Physiology 
and Biochemistry





adding FCS containing medium, the cells start to enter the cell cycle and samples are taken 72 hours after 
	ǤȀʹΨϐǦǤ
Ǧ ȋͷͲρȀ ͳͳͲ6 cells in 500μl) was performed after 
ȋͳȀȌȋǡǤǡǡȌͳ͵͹ιǤ
	ȋǡ	ǡǡȌǤ
Osteogenic and adipogenic differentiation









Preparation of plasmids and retroviral transduction
A retroviral transduction system was established for generating a stable Sox9 gene knockdown in rASC. 







Ǧ ǡ   ȋ̻ʹǦʹͻ͵Ȍ
were used to transduce rASC.
Therefore, cells were seeded in P2 at a low density. After 24 hours of proliferation, the transduction 
was performed on three consecutive days by adding medium supernatant of the virus producing cells 
͸ρȀȋǡǤǡǡȌ
the ratio of 1:1 to the rASC. As controls for the Sox9 knockdown experiments, a scrambled shRNA containing 
virus was used. Subsequently, transduced rASCs were subjected to selection with puromycin (Sigma, St. 
ǡǡȌ   ͻǤͻ 
cells showing more than 50% reduction of Sox9 gene and protein expression were used for further analysis. 
Growth kinetics 





Td= doubling time, T: time when cell numbers increased from N0 to Nt; N0: initial cell numbers; Nt: 
ϐǤ
BrdU incorporation assay
   ϐ    Ȃ    ȋǡ ǡ 
Ȍ
according to manufacturer’s protocol. 
Transduced and selected cells were seeded in 96-well plates. After 24 hours, culture medium was 
   Ǥ   ʹͶ ǡ      
ȋǦ
ȌǤͶͷͲȀ͸ͻͲ
reader (Tecan, Männedorf, Swiss).
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   Ǧ  Ǧ͵Ȁ͹  ȋǡ 	ǡ ǡ Ȍ
  Ǧ͵Ȁ͹        ǯ
Ǥ  Ǧϐ   ȋǦǦͳͳͲȌǡ    ǡ   
ϐͷʹͳȋǡ¡ǡȌǤ
Protein extraction and Westernblot analysis
 ǡ  Ǧǡ   Ǥ  
ȋϐǡǡǡȌ
  ȋǡ ǡ 
ȌǤ       ϐ
  Ǧ ȋ ϐǡ ǡ ǡ Ȍ   ʹͷǦͷͲ ρ
protein (depending on the protein of interest) was boiled for 5 min with SDS-sample buffer containing 
éǦ ͳͲΨǦͳʹΨǦ
Ǥ ǡ 












Table 1. Primer sequences for real-time PCR
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ϐ    ͷͲρ    ȋȌ     
̵ȋǡǡȌǤ
samples were read at 450 nm in duplicate using a microplate reader (Tecan, Männedorf, Switzerland).
RNA isolation and real time RT-PCR
Total RNA was isolated using Stratagene’s Absolutly RNA Miniprep Kit (Stratagene, La Jolla, California, 





The cDNA copy number of Sox9 in total RNA was measured using a standard curve generated with serially 
diluted plasmids containing the PCR amplicon sequences (range of cDNA copy number: 50-500.000 copies). 
ϐéǦ
using primers which are listed in Table 1. 
ϔ
Darkly stained area (dark red and black) were analysed densitometrically using Photoshop CS3. 






Immunophenotype and differentiation potential of rASC versus rBMSC 
We isolated mesenchymal stem cells from the subcutaneous adipose tissue (ASC) and 
ȋȌϐǦǡ
ʹǤǡϐ
 ǡ ϐ      
ȋ	ǤͳȌǤϐǡ
rASC as well as rBMSC, are more than 96% CD90 positive in passage 1 and 2, and nearly 
completely negative for CD45 and CD11b. In contrast to rASC however, rBMSC in passage 1 




    ϐ       ϐ  ǡ 
ϐ ͳʹ  alkaline 
 ȋȌǡ ͷͷǡ  ȋȌǡ ͷ͹ǡ ͸ǡ Ϳǡ Ƚ and Integrin 
ȽͷͷȋͷͷȌ, which are known to be important in stem cell biology and differentiation.
In passage 1 (P1), rASC displayed a 4-fold higher gene expression of Ƚas rBMSC. 
In contrast, Alp, Mmp13, Itga11 and osteocalcin gene expression was profoundly reduced 
in rASC compared to rBMSC. The gene expression level of Col1a1, Sox9 and Runx2 was not 
ϐȋ	ǤʹȌǤ
In passage 2 (P2), especially the expression of the transcription factor Sox9 was 
strikingly upregulated. Sox9 was more than 103-fold higher expressed in rASC compared 
to rBMSC. Also Runx2, VegfȽǡosteocalcin, Itga11 and Col1a1 gene expression was clearly 
induced in rASC while Mmp13 gene expression was downregulated and Alp was comparable 
to rBMSC (Fig. 2B).
As the Sox9 RNA level was highly induced in rASC compared to rBMSC, we determined 
Sox9 protein amount. Western blot analysis showed an increase of the Sox9 signal from P1 
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to P2 in rASC, whereas in rBMSC the signal strength remained approximately the same (Fig. 
2C). Comparison of Sox9 gene expression, calibrated on rASC P1, revealed a strong increase 
between P1 and P2 in rASC while in rBMSC Sox9 mRNA expression was reduced (Fig. 2D).
Retroviral-mediated Sox9 knockdown in rASC affected proliferation, p21 and Cyclin D1 
protein expression and gene expression of osteogenic markers 
ϐͻ 
compared to rBMSC in passage 2 (Fig. 2B, C, D), we addressed the role of this transcription 
factor in undifferentiated rASC with respect to cell growth and differentiation. Possibly, 
increased Sox9 expression is a major distinguishing feature between ASC and BMSC and 
might explain differences in the biology of these two adult stem cell types.
For a more detailed functional analysis of the transcription factor, we next stably silenced 
Sox9 ǤͻϐǤSox9 cDNA 
copies (per 100ng RNA) declined from about 12.000 to 4000 on average which is ~ 70% 
reduction of expression (Fig. 3A), and accordingly the protein signal was strongly reduced in 
western blots (Fig. 3B). In the following, Sox9 knockdown cells are termed “–SOX9” and all 
knockdown experiments were carried out with passage 2 rASC. 
One well known difference between ASC and BMSC is the higher proliferation rate of 
ǤǡͻǤ

kinetics demonstrated that after 72 hours of proliferation, the number of control cells 
Fig. 1. Characterization of osteo- and adipogenic differentiation and immunophenotype of rASC and rBMSC. 
a) Mineralization after osteogenic induction was visualized using Alizarin Red S staining, and lipid droplets 




= intensity log values, y-axes = cell counts. 
Cell Physiol Biochem 2013;31:703-717
DOI: 10.1159/000350089
Published online: May 16, 2013
© 2013 S. Karger AG, Basel
www.karger.com/cpb 710




compared to –SOX9 cells (Fig. 4A). From that data, we calculated a doubling time of –SOX9 
rASC of about 60,96 hours days while control cells needed about 52,56 hours.
ʹͲΨȂͻȋ	Ǥ
ͶȌ      ϐ    ϐ  
S-phase cells in the –SOX9 rASC population compared to control cells (Fig. 4C). 
Next we determined gene and protein expression of the cell cycle inhibitor p21 in –SOX9 
rASC and controls. The p21 protein signal was strongly increased in –SOX9 cells compared to 






 Ǧ  ͳǤ    ΪȀǦ Ǥ α ͶǢ ȗ δ ͲǡͲͷǤ c) Representative western blotting image 
demonstrates protein expression of Sox9 in rASC and rBMSC in P1 and P2. Cells were lysed in RIPA buffer 
Ǧ
ǤǡͻǦͻ
ǦéǦǤ n= 3. d) Sox9 gene expression for rASC and rBMSC in 
P1 and P2. Results are calibrated on rASC of P1, normalized to housekeeping gene E-actin, and show mean 
ΪȀǦǤαͶǢȗδͲǡͲͷǤ
Fig. 3. Silencing of Sox9 in rASC. Sox9 mRNA and 
protein expression after Sox9 knockdown was 
compared to mock-transfected control rASC. a) 
    ͹ͲΨ Sox9 
cDNA copies in retroviral transduced rASC. b) 
Western Blot analysis showed a strongly decreased 
Sox9 protein signal compared to control cells. 
ΪȀǦǤȗδͲǡͲͷǤα͸ 
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In addition, we analysed the protein and mRNA expression of cyclin D1, a cell cycle 
activator, after Sox9 knockdown. We observed an increase in cyclin D1 protein signal 
ȋ	Ǥ ͶȌ   ϐ     Ccnd1 (cyclin D1) in –SOX9 rASC 
ȋ	ǤͶȌǤ
ȋ	ǤͶȌ
(Fig. 4B) is not due to decreased cell viability in the –SOX9 rASC population, we determined 
Fig. 4. Proliferation and apoptosis in -SOX9 rASC. aȌ 
     ϐ
Ȃͻ͹ʹǤȌʹͲΨ
ȂͻǤȌ	Ȃͻ
S-phase population. d) Westernblot evaluation showed increased p21 and cyclin D1 protein signals in –SOX9 
ǤȌͳϐʹͳǤ
ΪȀǦǤȗδͲǡͲͷǢȗȗδͲǡͲͳǤαͶǤ 
Fig. 5. Analysis of apoptotic activity in -SOX9 rASC. 
Ȍ  ͵Ȁ͹    
changes in apoptotic activity of –SOX9 rASC versus 
Ǥ Ȍ   Ǧ Bcl-
2 was not regulated in –SOX9 rASC compared to 
ǤΪȀǦǤα͵Ǥ 
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and Bcl-2 mRNA level after Sox9 silencing and thus excluded alteration in apoptosis rate as a 
consequence of reduced proliferation.
Induction of osteocalcin and Mmp13 expression after Sox9 inhibition in undifferentiated 
rASC
As Sox9 downregulation is a prerequisite for osteogenic differentiation of progenitor 
ǡϐ
marker genes related to osteogenic differentiation in undifferentiated –SOX9 rASC.   
Among the thirteen analysed genes, only osteocalcin and Mmp13 mRNA levels were 
ϐͻȋ	Ǥ͸ȌǤ
of protein expression showed an increase of osteocalcin concentration in –SOX9 cell lysates 
ȋ	Ǥ͸ȌǤ	Ȃͻǡͳǡ͵ȂͲǡ͹Ȁ
ͲǡͻͲǡͷȀͷͲρǤDlx3, p300, Runx2, 
Col1a1, VegfD and Sox6  gene expression level were decreased in –SOX9 rASC compared to 
controls, whereas mRNA level of  Dlx5, Msx2, Sox5 and Itga11 were not affected.
Fig. 6. ȂͻǤȌ
    ͻ    Ǥ   ΪȀǦ Ǥ ȗ
δͲǡͲͷǢȗȗδͲǡͲͳǢȗȗȗδͲǡͲͲͳǢα͹Ǧͻ. b) Osteocalcin protein concentration in undifferentiated –SOX9 and 
   ȏȀȐͷͲρ ǢαͶǤ Ȍ
7,14 and 21 days of osteogenic differentiation in –SOX9 rASC which were calibrated on control cells and 
   Ǥ ΪȀǦ Ǥ ȗ δͲǡͲͷǢ αͶǤ Ȍ  
of –Sox9 rASC and control rASC after 21 days of osteogenic differentiation; Scale bar = 200μm; n=5. e) 
Densitometric measurement of Alizarin Red S stained areas by calculating the pixel number of stained 
nodules in relation to the pixel number of the total area. ΪȀǦǤȗδͲǡͲͷǢαͷǤ
Cell Physiol Biochem 2013;31:703-717
DOI: 10.1159/000350089
Published online: May 16, 2013
© 2013 S. Karger AG, Basel
www.karger.com/cpb 713
Stöckl/Göttl/Grifka/Grässel: Sox9 in Adipose-Derived Stem Cells
Cellular Physiology 
and Biochemistry
Increased gene expression of osteocalcin, Mmp13 and VegfD during osteogenic 
differentiation in –SOX9 rASC
Here, we analysed whether the progression of in vitro osteogenic differentiation is 
affected by the Sox9 dose in rASC. 
In undifferentiated –SOX9 rASC markers for late osteogenesis like osteocalcin and 
Mmp13 were induced, and the expression of early markers like Runx2, Col1a1 and VegfD 
were downregulated (Fig. 6A), however after 7 days of osteogenic differentiated, none of 
these genes was regulated at this time point (Fig. 6C). 

ͳͶ
osteocalcin ϐ ȂͻǡMmp13 and 
Alp, VegfD, Runx2 and Col1a1 were not regulated at that time point. However, after 21 days 
of osteogenesis, VegfD and Mmp13ϐosteocalcin 
by trend (Fig. 6C).
Alizarin Red S staining of the mineralized matrix at the end point at day 21 visualizes 
an increase in nodule formation for –SOX9 rASC compared to controls (Fig. 6D), which was 
ϐ
ȋ	Ǥ͸ȌǤ	ȂͻͻΨ
Alizarin Red S, whereas control cells display only 4% staining at average. 
Discussion
         ϐ  ǡ   
to compare them with the better characterized BMSC with respect to cell activity and 
Ǥǡϐ
and stem cell biology markers between undifferentiated rASC and rBMSC in passage 1 and 2 
ϐǤ
 Ƚͳͳß1 integrin receptor plays a major role in mediating the crosstalk and cell 
ȏ͵ʹȐǤǡ
higher Ƚͷͷ expression in rASC compared to rBMSC might indicate an advantage in 
cellular processes, such as cell adhesion, migration and differentiation in general between 
ǤǡȽͳͳ
level is associated with less differentiation pointing to a higher “stemness” of ASC even in 
later passages [33]. 
Among others, Runx2 is a crucial transcription factor that regulates bone formation 
during early embryogenesis. Our results indicated increased Runx2 expression in rASC 
versus rBMSC in passage 2 together with a profoundly induced Sox9 expression.  Runx2 is 
    Ǧϐ  Ǥ    ϐ 
induction of Runx2 commits MSC to osteogenesis through mediating expression of other 
osteogenic-target genes, such as Col1a1, and osteocalcin [34, 35]. In addition, Runx2 can 
also serve as a transcription factor to induce transcription of Ƚ which is regulated via 
ʹϐȏ͵͸ȐǤǡ
we noticed increasing osteocalcin gene expression in undifferentiated rASC in passage 2 
Ǥϐ
Ǥǡϐ
synthesized by osteoblasts and is a marker of osteoblast differentiation during the later 
stages of bone formation [37]. We unambiguously detected osteocalcin protein in cell 
lysates of undifferentiated rASC indicating extra functions of osteocalcin besides Ca2-binding 
which might be related to insulin metabolism. ǡ
can stimulate cyclin D1 and insulin gene expression plus proliferation markers in beta-
cells whereas nanomolar amounts induce adiponectin expression, an insulin-sensitizing 
adipokine, in adipocytes. Thus osteocalcin evolved as a novel molecular player which 
augments the effects of insulin and that way regulates glucose metabolisms and fat mass in 
the body [38, 39].  
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The most striking increase in gene and protein expression was found for transcription 
factor Sox9. Being on approximately the same level in rASC and rBMSC in P1, the mRNA level 
was up to 103-fold higher in rASC in comparison to rBMSC in P2 and moreover the protein 
level was clearly increased. That points to a crucial role for Sox9 in ASC which appears not to 
be restricted to differentiation processes per se.
To elucidate putative functions of Sox9 in undifferentiated rASC, we silenced Sox9 via 
retroviral transduction and analysed the downstream effects. We observed a clear decrease 
in proliferative activity of rASC without increase in apoptotic activity. Concomitantly, we 
detected an increased protein level of the cell cycle inhibitor p21, however without an 
increase in gene expression what points to a post-transcriptional regulation of p21 mRNA as 
it was already shown for 3T3-L1 pre-adipocytes [40]. We suggest that in native ASC, the p21 
protein signal decreases over passages which might be related to the higher Sox9 expression 
in rASC compared to rBMSC, as a Sox9 knockdown dramatically increases p21 protein 
expression indicating a pro-proliferative role of Sox9. This is in line with a recent report which 
described that the p21 expression is decreased in ASC compared to BMSC in patients with 
osteoporotic fractures, suggesting that this may be one reason for the higher proliferation 
potential of ASC. The authors concluded that proliferation and osteogenic differentiation of 
ASC were less affected by age and multiple passaging than BMSC, suggesting that ASC have 
the potential to become a more effective therapeutic option for cell-based therapy, especially 




S-phase transition [42], leading to the conclusion that the high p21 level in Sox9 knockdown 
cells impairs the S-phase entry. On the basis of observations from Peng et al. [43]  and other 
groups that observed a higher proliferation rate in ASC vs. BMSC, we suppose that at least 
in part, the profoundly higher Sox9 level in ASC contributes to the higher proliferation rate. 
As it is known that the cell cycle inhibitor p21 is closely related to cyclin D1, we also 
analysed cyclin D1 level in undifferentiated rASC. We observed an increase in cyclin D1 
protein together with the mRNA level as a consequence of Sox9 inhibition. That may suggest 
precocious senescence of the cells, according to Alt et al., who postulated that the accumulation 
of cyclin D1 in senescent cells may be due to elevated level of p21 [44] . Consequently, Sox9 is 
not only pro-proliferative, but also might prevent the cells from undergoing early senescence, 
what again supports the importance of proper Sox9 expression in undifferentiated stem 
ǤǦͳϐ
the proteasome-mediated degradation of p21 [45], hence a strongly elevated cyclin D1 level 
might potentiate delay in cell cycle progression by stabilizing p21 protein.
       ǡ ͳǡ    éǦǡ
      ϐ    
various developmental stages during calvarial morphogenesis. Mirando et al. showed several 
ͳǦȀǦǡϐǡ
decreased mineralization and a wider suture region and suggest as underlying mechanism 
an impairment of osteoblast development caused by the loss of cyclin D1 [46].  This is 
ϐ
and osteogenic induced rASC after Sox9 inhibition revealed an induction of osteocalcin and 
Mmp13 suggesting a pro-osteogenic effect after Sox9 inhibition which in part might be 
mediated through cyclin D1. 
Notably, VegfD, Sox6, Col1a1, Dlx3, p300 and Runx2 were down regulated in 
undifferentiated -SOX9 cells indicating a decrease in the general differentiation capacity of 
MSC. Most likely, the impact of the transcription factor Sox9 is strictly differentiation stage 
ϐǡǦͻ
osteoblastic differentiation while early in development Sox9 is required to maintain growth 
plate chondrocyte proliferation [47]. Notably, the proliferation rate of expanded MSC showed 
a positive correlation with chondrogenesis suggesting that growth and differentiation steps 
are closely coordinated and resemble stages known from embryonic cartilage development 
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[48]. Possibly, too early inhibition of Sox9 expression in still undifferentiated MSC in general 
impairs proliferation and in consequence also differentiation capacity of the cells. 
The clear upregulation of osteocalcin and Mmp13 in undifferentiated –SOX9 rASC was 
accompanied by a decrease of Runx2 and its co-factors p300, Dlx3 and VegfD. As all of these 
genes are associated to osteogenic differentiation, we have exposed –SOX9 rASC to in vitro 
ʹͳǤϐ
of ASC. Hayashi et al. was unable to detect matrix formation or osteocalcin expression in 
rASC [49] whereas other groups described and characterized the osteogenic differentiation 
potential of ASC in detail [50, 51]. We clearly observed calcium matrix deposits and measured 
osteocalcin mRNA and osteocalcin protein expression under osteogenic favourable culture 
conditions. During the early phase of osteogenic differentiation, none of the analysed 
osteogenic marker were regulated in –SOX9 cells, however, on day 14 and day 21, gene 
expression of osteocalcin, VegfD and Mmp13 was induced. Accordingly, we conclude that 
Sox9 has no impact on early osteogenic differentiation whereas the expression of osteogenic 
markers in later phases of in vitro osteogenesis were induced when Sox9 dose was less than 
50% of controls. Moreover, after 21 days calcium mineralization deposits, as an indicator of 
ǡϐȂͻǤ
Ǧͳ͵
Sox9 in human MSC and differentiated them into chondrocytes [52], and Liang et al. reported 
    Ǧϐ ͻ  ȋͳͳǦͻ Ȍ
ϐȏͷ͵ȐǤǡ
effect of Sox9 on osteocalcin and Mmp13 gene expression, as both are upregulated after Sox9 
knockdown in undifferentiated and osteogenic differentiated rASC.
Conclusion
In conclusion, our study suggest that Sox9 has a pro-proliferative effect in undifferentiated 
rASC, presumably via regulation of p21 and cyclin D. Notably,  apoptosis rate and apoptosis 
ͻǤͻδͷͲΨ
of controls impairs proliferation and increases the expression of differentiation related 
markers as osteocalcin and Mmp13 in undifferentiated and osteogenic differentiated rASC, 
suggesting the existence of regulatory mechanism of Sox9 with respect to these genes. We 
suggest that cyclin D1 might be a candidate for mediating the anti-proliferative and pro-
osteogenic effects in our rASC study when the Sox9 level is critically reduced. 
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